Alibaba’s mobile internet subsidiary is launching the InDev program through its 9Apps app store and will invest in up to 100 India-based game developers.
Month: April 2016
Corporates look to grow Acorns with $30m
Automated micro-investment service Acorns has raised $30m from backers including Rakuten and PayPal to take its overall funding to $62m.
The RealReal boosts riches by $40m
The Novel-backed luxury items marketplace has now raised $123m since 2011 and aims to become profitable this year, with an IPO to come in around 2018.
GV finds happy Medium for $50m series C
Publishing platform Medium boosted its total funding to more than $130m in a GV-backed round that reportedly valued it at $600m.
Paytm carries Jugnoo to $10m series B
The online payment company invested $5m to lead a $10m round for the auto rickshaw hailing platform, after participating in its series A round last year.
Deutsche Bank increases Silicon Valley focus
The financial services firm has opened an innovation lab in Silicon Valley in partnership with IBM, following similar initiatives in London and Berlin last year.
Roseonly blooms with $29m
The Tencent and IDG-backed luxury goods and flowers retailer has raised series C funding that will help it expand its physical store network.
AB InBev makes Techstars Connection
Beverage company AB InBev is partnering Techstars to launch a New York-based brewing and social technology accelerator called Techstars Connection.
Tencent-backed eJiaJie completes Neeq listing
The app-based home cleaning service has floated on the National Equities Exchange and Quotations market after raising four rounds of funding from investors including Tencent and Shanda.
Gemphire lights IPO fuse
The dyslipidemia treatment developer has filed for a $60m initial public offering that will allow Pfizer, from which it licensed its lead candidate, to exit.
Avantium advances with $22.7m
Avantium, which launched a joint venture with BASF last month, has added Flanders’ investment firm PMV and federal holding company FPIM to its shareholders.
Alcon turns on series D funding for PowerVision
US-based eyecare technology developer PowerVision has extended its series D round to $40m, according to a regulatory filing on Tuesday, having secured funding from Alcon, an eyecare subsidiary of pharmaceutical firm Novartis. Founded in 2002, PowerVision is developing an intraocular implant for patients suffering from cataracts and presbyopia, a type of farsightedness associated with old… Continue reading Alcon turns on series D funding for PowerVision
Legend’s Hony closes $2.7bn dual-currency fund
Hony Capital, which acts as conglomerate Legend Holdings’ private equity arm, has raised a fund in which 70% of the capital is dollars and the rest is renminbi.
Second Genome raises $42.6m in third funding round
US-based biopharmaceutical company Second Genome raised $42.6m yesterday in a series B round co-led by pharmaceutical firms Pfizer and Roche, which invested through their respective Pfizer Venture Investments and Roche Venture Fund units. Medical research organisation Mayo Clinic also took part in the round, as did Digitalis Ventures, Adveq, LifeForce Capital, MBL Venture Capital, Advanced… Continue reading Second Genome raises $42.6m in third funding round